nodes	percent_of_prediction	percent_of_DWPC	metapath
Tubocurarine—ACHE—Irinotecan—lung cancer	0.261	0.505	CbGbCtD
Tubocurarine—SLC22A2—Vinblastine—lung cancer	0.133	0.258	CbGbCtD
Tubocurarine—SLC22A2—Cisplatin—lung cancer	0.122	0.237	CbGbCtD
Tubocurarine—CHRND—pericardium—lung cancer	0.039	0.582	CbGeAlD
Tubocurarine—CHRNA2—mammary gland—lung cancer	0.00773	0.115	CbGeAlD
Tubocurarine—CHRND—respiratory system—lung cancer	0.00744	0.111	CbGeAlD
Tubocurarine—CHRND—lung—lung cancer	0.00395	0.0589	CbGeAlD
Tubocurarine—HTR3A—respiratory system—lung cancer	0.00368	0.0549	CbGeAlD
Tubocurarine—HTR3A—lung—lung cancer	0.00195	0.0291	CbGeAlD
Tubocurarine—CHRNB1—lymph node—lung cancer	0.00174	0.026	CbGeAlD
Tubocurarine—ACHE—lymph node—lung cancer	0.00151	0.0225	CbGeAlD
Tubocurarine—SLC22A1—Metabolism—B4GALT5—lung cancer	5.99e-05	0.000144	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ADCY1—lung cancer	5.95e-05	0.000143	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ABCG2—lung cancer	5.95e-05	0.000143	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—MMP1—lung cancer	5.95e-05	0.000143	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—ABCB1—lung cancer	5.89e-05	0.000141	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—COL4A2—lung cancer	5.88e-05	0.000141	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTA1—lung cancer	5.88e-05	0.000141	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PTHLH—lung cancer	5.86e-05	0.000141	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ENO2—lung cancer	5.83e-05	0.00014	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—HPGDS—lung cancer	5.83e-05	0.00014	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTA4—lung cancer	5.83e-05	0.00014	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ABCC3—lung cancer	5.81e-05	0.00014	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PPP2R1B—lung cancer	5.8e-05	0.000139	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GIPR—lung cancer	5.73e-05	0.000138	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ADCY1—lung cancer	5.72e-05	0.000137	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.72e-05	0.000137	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTA2—lung cancer	5.68e-05	0.000136	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTT1—lung cancer	5.66e-05	0.000136	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—AKR1C1—lung cancer	5.63e-05	0.000135	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GCLC—lung cancer	5.59e-05	0.000134	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP2A6—lung cancer	5.59e-05	0.000134	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PPP2R1B—lung cancer	5.57e-05	0.000134	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.57e-05	0.000134	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—lung cancer	5.57e-05	0.000134	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ANXA1—lung cancer	5.51e-05	0.000132	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	5.49e-05	0.000132	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTA1—lung cancer	5.48e-05	0.000132	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—UGT1A1—lung cancer	5.47e-05	0.000131	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ABCC3—lung cancer	5.42e-05	0.00013	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SDC4—lung cancer	5.35e-05	0.000128	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PTHLH—lung cancer	5.32e-05	0.000128	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ENO1—lung cancer	5.3e-05	0.000127	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.28e-05	0.000127	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GNG11—lung cancer	5.27e-05	0.000126	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—AKR1C1—lung cancer	5.25e-05	0.000126	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DUSP3—lung cancer	5.24e-05	0.000126	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—APP—lung cancer	5.22e-05	0.000125	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.21e-05	0.000125	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—RHEB—lung cancer	5.14e-05	0.000123	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—UGT1A1—lung cancer	5.09e-05	0.000122	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ALDOA—lung cancer	5.02e-05	0.00012	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ANXA1—lung cancer	5e-05	0.00012	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—APOA1—lung cancer	4.99e-05	0.00012	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—POMC—lung cancer	4.94e-05	0.000119	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GNG11—lung cancer	4.91e-05	0.000118	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GRM8—lung cancer	4.87e-05	0.000117	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NCOA3—lung cancer	4.87e-05	0.000117	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	4.85e-05	0.000116	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—HRAS—lung cancer	4.78e-05	0.000115	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—POMC—lung cancer	4.77e-05	0.000115	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP2E1—lung cancer	4.76e-05	0.000114	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—IL6—lung cancer	4.75e-05	0.000114	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—APP—lung cancer	4.74e-05	0.000114	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ADCY1—lung cancer	4.74e-05	0.000114	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ABCG2—lung cancer	4.74e-05	0.000114	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SKI—lung cancer	4.72e-05	0.000113	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—NQO1—lung cancer	4.7e-05	0.000113	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ALDOA—lung cancer	4.68e-05	0.000112	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ENO2—lung cancer	4.65e-05	0.000112	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—HPGDS—lung cancer	4.65e-05	0.000112	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—APOA1—lung cancer	4.65e-05	0.000112	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PPP2R1B—lung cancer	4.62e-05	0.000111	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.6e-05	0.00011	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—MMP2—lung cancer	4.6e-05	0.00011	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—HRAS—lung cancer	4.59e-05	0.00011	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.56e-05	0.000109	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NCOA3—lung cancer	4.54e-05	0.000109	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTT1—lung cancer	4.51e-05	0.000108	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GCLC—lung cancer	4.46e-05	0.000107	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP2A6—lung cancer	4.46e-05	0.000107	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—HRAS—lung cancer	4.45e-05	0.000107	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ABCG2—lung cancer	4.42e-05	0.000106	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ADCY1—lung cancer	4.42e-05	0.000106	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—HPGDS—lung cancer	4.33e-05	0.000104	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ENO2—lung cancer	4.33e-05	0.000104	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PPP2R1B—lung cancer	4.3e-05	0.000103	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—STK11—lung cancer	4.24e-05	0.000102	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ENO1—lung cancer	4.22e-05	0.000101	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—CREBBP—lung cancer	4.22e-05	0.000101	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTT1—lung cancer	4.2e-05	0.000101	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GCLC—lung cancer	4.15e-05	9.97e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP2A6—lung cancer	4.15e-05	9.97e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PXN—lung cancer	4.1e-05	9.84e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—AVP—lung cancer	4.06e-05	9.74e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AKR1C1—lung cancer	4.01e-05	9.63e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—OXTR—lung cancer	4.01e-05	9.63e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GRP—lung cancer	4.01e-05	9.63e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.98e-05	9.55e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—ALB—lung cancer	3.95e-05	9.48e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ENO1—lung cancer	3.94e-05	9.45e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—CREBBP—lung cancer	3.93e-05	9.44e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTP1—lung cancer	3.92e-05	9.41e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—CXCL8—lung cancer	3.82e-05	9.17e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CAT—lung cancer	3.82e-05	9.16e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.79e-05	9.1e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP2E1—lung cancer	3.79e-05	9.09e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GNG11—lung cancer	3.76e-05	9.02e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NQO1—lung cancer	3.75e-05	8.99e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ABCB1—lung cancer	3.71e-05	8.91e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CXCL8—lung cancer	3.69e-05	8.86e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—AVP—lung cancer	3.69e-05	8.84e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—ALB—lung cancer	3.68e-05	8.84e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—HRAS—lung cancer	3.66e-05	8.78e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—TYMS—lung cancer	3.65e-05	8.75e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTM1—lung cancer	3.6e-05	8.65e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VEGFC—lung cancer	3.58e-05	8.59e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—RAF1—lung cancer	3.57e-05	8.57e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP2E1—lung cancer	3.53e-05	8.47e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NQO1—lung cancer	3.49e-05	8.38e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP1A1—lung cancer	3.42e-05	8.2e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—HRAS—lung cancer	3.41e-05	8.18e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ERCC2—lung cancer	3.39e-05	8.13e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ADCY1—lung cancer	3.38e-05	8.11e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—STK11—lung cancer	3.38e-05	8.1e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—RAF1—lung cancer	3.33e-05	7.99e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PPP2R1B—lung cancer	3.29e-05	7.9e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SMARCA4—lung cancer	3.29e-05	7.9e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HSPB1—lung cancer	3.18e-05	7.62e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—STK11—lung cancer	3.15e-05	7.55e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTHLH—lung cancer	3.14e-05	7.54e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTP1—lung cancer	3.12e-05	7.5e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CAT—lung cancer	3.04e-05	7.3e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ABCB1—lung cancer	2.96e-05	7.1e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ANXA1—lung cancer	2.95e-05	7.09e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—APOA1—lung cancer	2.93e-05	7.03e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTP1—lung cancer	2.91e-05	6.99e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—TYMS—lung cancer	2.9e-05	6.97e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTM1—lung cancer	2.87e-05	6.89e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FLT1—lung cancer	2.86e-05	6.86e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CAT—lung cancer	2.83e-05	6.8e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CG—lung cancer	2.83e-05	6.8e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.81e-05	6.73e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NOTCH3—lung cancer	2.8e-05	6.72e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APP—lung cancer	2.8e-05	6.72e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FGF9—lung cancer	2.78e-05	6.66e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ABCB1—lung cancer	2.76e-05	6.62e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP1A1—lung cancer	2.72e-05	6.53e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—TYMS—lung cancer	2.71e-05	6.5e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ERCC2—lung cancer	2.7e-05	6.48e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—POMC—lung cancer	2.7e-05	6.47e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTM1—lung cancer	2.68e-05	6.42e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CG—lung cancer	2.68e-05	6.42e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—JUNB—lung cancer	2.65e-05	6.36e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CG—lung cancer	2.57e-05	6.17e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—POMC—lung cancer	2.55e-05	6.11e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP1A1—lung cancer	2.54e-05	6.09e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ERCC2—lung cancer	2.52e-05	6.04e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CD—lung cancer	2.49e-05	5.98e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CREBBP—lung cancer	2.48e-05	5.95e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—POMC—lung cancer	2.45e-05	5.88e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—STK11—lung cancer	2.41e-05	5.78e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL6R—lung cancer	2.39e-05	5.73e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CD—lung cancer	2.35e-05	5.64e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—APOA1—lung cancer	2.34e-05	5.6e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FOXO3—lung cancer	2.32e-05	5.58e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ALB—lung cancer	2.32e-05	5.57e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	2.28e-05	5.46e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	2.26e-05	5.43e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AVP—lung cancer	2.18e-05	5.22e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—APOA1—lung cancer	2.18e-05	5.22e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	2.17e-05	5.21e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CG—lung cancer	2.13e-05	5.12e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IGF1R—lung cancer	2.1e-05	5.03e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	2.09e-05	5.01e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HES1—lung cancer	2.06e-05	4.94e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CB—lung cancer	2.05e-05	4.92e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTGS2—lung cancer	2.03e-05	4.88e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—POMC—lung cancer	2.03e-05	4.87e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—RAF1—lung cancer	2.02e-05	4.85e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—IL2—lung cancer	1.99e-05	4.78e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CG—lung cancer	1.99e-05	4.77e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CREBBP—lung cancer	1.98e-05	4.74e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	1.97e-05	4.73e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CXCL8—lung cancer	1.89e-05	4.55e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—POMC—lung cancer	1.89e-05	4.54e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ERBB3—lung cancer	1.88e-05	4.52e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CD—lung cancer	1.87e-05	4.5e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ALB—lung cancer	1.85e-05	4.44e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CREBBP—lung cancer	1.84e-05	4.42e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL2—lung cancer	1.81e-05	4.35e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TERT—lung cancer	1.8e-05	4.33e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTEN—lung cancer	1.77e-05	4.25e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FGFR1—lung cancer	1.75e-05	4.2e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CD—lung cancer	1.75e-05	4.19e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HIF1A—lung cancer	1.73e-05	4.14e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ALB—lung cancer	1.72e-05	4.14e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—EP300—lung cancer	1.69e-05	4.05e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APOA1—lung cancer	1.66e-05	4e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KDR—lung cancer	1.65e-05	3.96e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CB—lung cancer	1.63e-05	3.92e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTGS2—lung cancer	1.62e-05	3.88e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CB—lung cancer	1.52e-05	3.65e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APC—lung cancer	1.52e-05	3.65e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KIT—lung cancer	1.52e-05	3.65e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CG—lung cancer	1.52e-05	3.65e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—NRAS—lung cancer	1.52e-05	3.65e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTGS2—lung cancer	1.51e-05	3.62e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EGF—lung cancer	1.5e-05	3.61e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—MAPK3—lung cancer	1.46e-05	3.49e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—POMC—lung cancer	1.45e-05	3.47e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—BRAF—lung cancer	1.43e-05	3.43e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTEN—lung cancer	1.41e-05	3.39e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL6R—lung cancer	1.41e-05	3.39e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CREBBP—lung cancer	1.41e-05	3.38e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—EGFR—lung cancer	1.38e-05	3.32e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—EP300—lung cancer	1.35e-05	3.23e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MAP2K1—lung cancer	1.35e-05	3.23e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CD—lung cancer	1.34e-05	3.21e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	1.32e-05	3.18e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTEN—lung cancer	1.32e-05	3.16e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—KRAS—lung cancer	1.31e-05	3.14e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—EP300—lung cancer	1.25e-05	3.01e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CA—lung cancer	1.25e-05	3e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.2e-05	2.88e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MDM2—lung cancer	1.2e-05	2.87e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—RAF1—lung cancer	1.19e-05	2.86e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ERBB2—lung cancer	1.18e-05	2.83e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CB—lung cancer	1.16e-05	2.79e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MTOR—lung cancer	1.16e-05	2.79e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CXCL8—lung cancer	1.12e-05	2.69e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—HRAS—lung cancer	1.11e-05	2.67e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—AKT1—lung cancer	1.08e-05	2.59e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CASP3—lung cancer	1.07e-05	2.57e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL2—lung cancer	1.07e-05	2.57e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL6—lung cancer	1.06e-05	2.55e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCND1—lung cancer	1.04e-05	2.5e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—JUN—lung cancer	1.04e-05	2.5e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—AKT1—lung cancer	1.02e-05	2.45e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MMP9—lung cancer	1.01e-05	2.43e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.01e-05	2.42e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTEN—lung cancer	1.01e-05	2.42e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CA—lung cancer	9.96e-06	2.39e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—AKT1—lung cancer	9.82e-06	2.36e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EP300—lung cancer	9.6e-06	2.3e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SRC—lung cancer	9.33e-06	2.24e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CA—lung cancer	9.28e-06	2.23e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VEGFA—lung cancer	9.09e-06	2.18e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—STAT3—lung cancer	9e-06	2.16e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NRAS—lung cancer	8.98e-06	2.15e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MAPK3—lung cancer	8.6e-06	2.06e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MYC—lung cancer	8.36e-06	2.01e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EGFR—lung cancer	8.18e-06	1.96e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—AKT1—lung cancer	8.14e-06	1.95e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KRAS—lung cancer	7.73e-06	1.85e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—AKT1—lung cancer	7.58e-06	1.82e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	7.1e-06	1.7e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TP53—lung cancer	6.87e-06	1.65e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HRAS—lung cancer	6.57e-06	1.58e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL6—lung cancer	6.29e-06	1.51e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AKT1—lung cancer	5.8e-06	1.39e-05	CbGpPWpGaD
